Dovonex and Rabeprazole drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Dovonex (calcipotriene) and Rabeprazole (rabeprazole sodium). Common drug interactions include pneumocystis jiroveci pneumonia among females and back pain among males.
The phase IV clinical study analyzes what interactions people have when they take Dovonex and Rabeprazole. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Dovonex?
Dovonex has active ingredients of calcipotriene. It is often used in psoriasis. eHealthMe is studying from 3,035 Dovonex users. Check the latest studies of Dovonex.
What is Rabeprazole?
Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.
16 people who take Dovonex and Rabeprazole together, and have interactions are studied.

What are the common drug interactions of Dovonex and Rabeprazole, by gender? *:
female:
- Pneumocystis jiroveci pneumonia (fungal infection of the lungs)
- Anaemia (lack of blood)
- Ascites (accumulation of fluid in the abdominal cavity)
- Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
- Cellulitis (infection under the skin)
- Drug eruption (adverse drug reaction of the skin)
- Hepatitis c
- Histiocytosis haematophagic
- Infection
- Multi-organ failure (multisystem organ failure)
male:
- Back pain
- Abdominal pain upper
- Melaena (the passage of black, tarry stools)
- Mouth haemorrhage (bleeding from mouth)
- Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
- Pyrexia (fever)
- Central nervous system necrosis (destruction of central nervous system)
- Confusional state
- Constipation
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
What are the common drug interactions of Dovonex and Rabeprazole, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Back pain
- Central nervous system necrosis (destruction of central nervous system)
- Confusional state
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Dyspnoea (difficult or laboured respiration)
- Melaena (the passage of black, tarry stools)
- Mouth haemorrhage (bleeding from mouth)
- Pyrexia (fever)
40-49:
- Anaemia (lack of blood)
- Ascites (accumulation of fluid in the abdominal cavity)
- Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
- Cellulitis (infection under the skin)
- Drug eruption (adverse drug reaction of the skin)
- Hepatitis c
- Histiocytosis haematophagic
- Infection
- Multi-organ failure (multisystem organ failure)
- Platelet count decreased
50-59:
- Pneumocystis jiroveci pneumonia (fungal infection of the lungs)
- Abdominal discomfort
- Headache (pain in head)
60+:
- Ear infection
- Haemorrhoids (a swollen vein or group of veins in the region of the anus)
- Monocyte count decreased
- Monocyte count increased
- White blood cell count decreased
- Constipation
- Death
- Herpes zoster
- Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
- Hallucination, auditory (perceiving sounds without auditory stimulus)
What are the existing conditions these people have? *
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 7 people, 43.75%
- Insomnia (sleeplessness): 4 people, 25.00%
- High Blood Pressure: 4 people, 25.00%
- Hepatitis C: 4 people, 25.00%
- High Blood Cholesterol: 3 people, 18.75%
- Dyslipidaemia (abnormal amount of lipids): 3 people, 18.75%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 12.50%
- Rashes (redness): 2 people, 12.50%
- Nail Disorder (disease of nail): 2 people, 12.50%
- Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 2 people, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take Dovonex and Rabeprazole?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Dovonex (3,035 reports)
- Rabeprazole (31,689 reports)
Browse all drug interactions of Dovonex and Rabeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dovonex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rabeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dovonex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rabeprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on calcipotriene and rabeprazole sodium (the active ingredients of Dovonex and Rabeprazole, respectively), and Dovonex and Rabeprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fingolimod and Light-Headedness When Standing Up for Women aged 50-59 - 8 seconds ago
- Fingolimod and Lightheadedness for Women aged 50-59 - 9 seconds ago
- Fingolimod and Vertigo for Women aged 50-59 - 9 seconds ago
- Fingolimod and Loss Of Balance for Women aged 50-59 - 9 seconds ago
- Fingolimod and Lightheadedness - Dizzy for Women aged 50-59 - 9 seconds ago
- Fingolimod and Dizziness for Women aged 50-59 - 10 seconds ago
- White Blood Cell Count Increased and drugs of ingredients of ketorolac tromethamine - 10 seconds ago
- Proventil and Nephrogenic Anaemia for Women aged 50-59 - 14 seconds ago
- Drug interactions of Nicotrol and Simvastatin - 41 seconds ago
- Could Dulcolax cause Bladder Disorder? - 42 seconds ago